Aptevo Therapeutics Inc. (APVO) vs UNITY Biotechnology, Inc. (UNBX)

Aptevo Therapeutics Inc. and UNITY Biotechnology, Inc. are both Biotechnology companies. Aptevo Therapeutics Inc. and UNITY Biotechnology, Inc. are of similar size ($3.4M and $3.4M). UNITY Biotechnology, Inc. has negative trailing earnings, so its P/E is not meaningful; Aptevo Therapeutics Inc. trades at 0.0×. Across the 7 metrics below, Aptevo Therapeutics Inc. leads on 4 and UNITY Biotechnology, Inc. on 3.

Valuation

Metric APVO UNBX Biotechnology median
P/E 0.00 n/m 7.88
P/S 0.17 n/m 11.47
P/B 0.37 n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 0.00 n/m 10.73
Earnings yield 86,377.14% (2,700.00%) (28.84%)
Free cash flow yield (1,127.28%) (2,174.64%) (23.03%)

Profitability

Metric APVO UNBX Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (446.89%) (231.27%) (57.72%)
Return on assets (186.29%) (61.66%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric APVO UNBX Biotechnology median
Revenue growth (TTM) 92.94% — 5.64%
EPS growth (last fiscal year) 99.72% 42.96% —
Revenue growth, 5-year CAGR (26.64%) — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric APVO UNBX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.08 1.95 4.73
Net debt to EBITDA 0.83 0.82 0.96

Dividend

Metric APVO UNBX Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric APVO UNBX Biotechnology median
Market cap 3.43m 3.44m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack